Could plasma sphingolipids be diagnostic or prognostic biomarkers for Alzheimer's disease?
about
Recent advances in the application of metabolomics to Alzheimer's DiseaseSphingolipids in spinal cord injuryCeramides in Alzheimer's Disease: Key Mediators of Neuronal Apoptosis Induced by Oxidative Stress and Aβ AccumulationCerebrospinal fluid sphingolipids, β-amyloid, and tau in adults at risk for Alzheimer's disease.Network Analysis of a Comprehensive Knowledge Repository Reveals a Dual Role for Ceramide in Alzheimer's Disease.Peripheral sphingolipids are associated with variation in white matter microstructure in older adults.Plasma lipidome is independently associated with variability in metabolic syndrome in Mexican American families.Biological Effects of Naturally Occurring Sphingolipids, Uncommon Variants, and Their Analogs.Metabolomic-guided discovery of Alzheimer's disease biomarkers from body fluid.The Association Between Plasma Ceramides and Sphingomyelins and Risk of Alzheimer's Disease Differs by Sex and APOE in the Baltimore Longitudinal Study of Aging.Expert consensus document: Mind the gaps—advancing research into short-term and long-term neuropsychological outcomes of youth sports-related concussions.Plasma Ceramides and Neuropsychiatric Symptoms of Alzheimer's Disease.Pleiotropic Effect of Human ApoE4 on Cerebral Ceramide and Saturated Fatty Acid Levels.The 14th International Conference on Alzheimer's Drug Discovery, 9 - 10 September 2013, in Jersey City, New Jersey.
P2860
Q26828606-AEBDBF43-C060-4A59-ACC2-19421313AB41Q27026103-9604ADEF-8011-475A-8EFE-0567E277F654Q28087030-9A0D3E79-C2AA-429D-B7D7-9BBB9373AB1DQ34223125-DD9C5841-A6D8-4226-9304-2A563B29D6D8Q35915842-D5959B72-D7D3-44CC-9840-7AA4406B7E53Q36973077-FC3851FA-80FF-47C4-9F00-99BDA9B2902FQ37716371-DFB9F1CF-F081-4196-815A-BA0B6D6645A3Q38890587-E4243F47-2BC9-4A92-ABF2-3D97925B640EQ39181900-7B7BE994-C67D-484E-A030-2A2DA08CDBDAQ40401973-103D3D07-D9F5-4FEA-8949-DA1783F67574Q45010732-32EC9096-3FAC-4004-AA5F-60B740B9DD44Q46563505-01C4EC95-2ED6-473D-836A-3F449AD1F93DQ47840266-35359825-A4BF-401C-9015-60C2E619369BQ53096518-6F45B27E-FC58-442E-A5C3-203BA7922975
P2860
Could plasma sphingolipids be diagnostic or prognostic biomarkers for Alzheimer's disease?
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Could plasma sphingolipids be ...... rkers for Alzheimer's disease?
@ast
Could plasma sphingolipids be ...... rkers for Alzheimer's disease?
@en
type
label
Could plasma sphingolipids be ...... rkers for Alzheimer's disease?
@ast
Could plasma sphingolipids be ...... rkers for Alzheimer's disease?
@en
prefLabel
Could plasma sphingolipids be ...... rkers for Alzheimer's disease?
@ast
Could plasma sphingolipids be ...... rkers for Alzheimer's disease?
@en
P2860
P356
P1433
P1476
Could plasma sphingolipids be ...... rkers for Alzheimer's disease?
@en
P2093
Michelle M Mielke
Norman J Haughey
P2860
P304
P356
10.2217/CLP.12.59
P577
2012-10-01T00:00:00Z